Skip to content

Gender Differences in Mild Depression: A Multi-Omics Analysis

Gender Differences in Mild Depression: A Multi-Omics Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110892
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild depression

Interventions

Observation group:Not applicable

Sponsors

Ningxia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1.Meets the diagnostic criteria for mild depression; 2. Hamilton Depression Rating Scale (HAMD-17) score: 7 < HAMD total score < 17; 3. No gender restrictions, aged between 18 and 55; 4. First onset, no prior medication treatment; 5. Able to complete questionnaires independently, give informed consent, and participate voluntarily.

Exclusion criteria

Exclusion criteria: 1.Patients with clinically diagnosed moderate to severe depression, or patients with previous psychiatric disorders or organic mental disorders; 2. Patients with severe diseases of the heart, brain, liver, kidney, hematopoietic system, etc.; 3. Pregnant or breastfeeding women; 4. Depressive episodes caused by psychoactive substances or non-addictive substances; 5. Known alcoholics or substance-dependent individuals; 6. Patients with strong suicidal intentions or behaviors; 7. Patients currently participating in other clinical trials; 8. Patients who have received antidepressant treatment; 9. Age over 55 or under 18 years; Individuals meeting any of the above criteria shall be excluded.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale (HAMD-17) score;Self-rating Depression Scale (SDS);Self-rating Anxiety Scale (SAS);Beck Depression Inventory (BDI-II) score;Serum untargeted metabolomics;Functional Magnetic Resonance Imaging;Fecal metagenomics;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index (PSQI);

Countries

China

Contacts

Public ContactLin Haixiong

Ningxia Medical University

lhxiong@foxmail.com+86 137 6330 9136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026